ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

In Congress: Funds Unavailable To Give NIH Big Raise, Appropriators Say

June 5, 1998

NIH Selects 16 Clinical Centers for Women’s Health Initiative

April 9, 1993

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

Rumors Preceded Broder’s Move

December 22, 1994

NIH Reauthorization Still Lingering, Bills ‘Tie Hands’ Of NCI Director

October 18, 1991

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978